Pharmaceutical Strategies Group Mergers & Acquisitions

Pharmaceutical Strategies Group M&A Summary

Pharmaceutical Strategies Group has acquired 1 company of its own. It has also divested 2 assets.

It’s largest disclosed sale occurred in 2020, when it sold Pharmaceutical Strategies Group - 340B Software-Enabled Service Business to Omnicell for $225M. Pharmaceutical Strategies Group has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (100%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity1
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 2

Pharmaceutical Strategies Group

Pharmaceutical Strategies Group LLC

5360 Legacy Drive, Building 4, Suite 110,
Plano, Texas 75024
United States,
(800) 687-4404
www.psgconsults.com

All (3) Buy (1) Sell (2)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-08-12 Pharmaceutical Strategies Group LLC - 340B Software-Enabled Service Business · Information Technology
Plano, Texas

Pharmaceutical Strategies Group LLC - 340B Software-Enabled Service Business provides a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner.

225 Divestiture

Omnicell
Advisors: Greenhill & Co. , Sidley

Pharmaceutical Strategies Group
Advisors: Houlihan Lokey , Norton Rose Fulbright


Try Mergr Free — See This and 220,876+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.